M2D2 IMPACT Cycle 6 Accelerator Pitch-Off

## About this event

### Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, and Life Sciences Industry Professionals:

Join the Massachusetts life sciences community as the startups from the Cycle 6 Cohort pitch their medical device solution to a panel of judges. These startups are working with M2D2 to advance the commercialization of their technology through the IMPACT Accelerator Program, sponsored by a group of stakeholders from medtech organizations.

## AGENDA:

4:00 Registration and networking
5:00 Event start/pitches
7:00 Networking (+ Prize announcements)
8:00 Program close

## What is IMPACT?

The M2D2 IMPACT program is a 12-week accelerator program that will run for 6 cycles. The program aims to advance early-stage companies looking to reshape the future of healthcare. Selected companies will have the opportunity to engage with our sponsors' specialized research calls to help advance their business.
Each IMPACT Cycle closes with an IMPACT Accelerator Pitch-Off. The startups involved in the current cycle will pitch their technology to a panel of experts and innovators on medical device development.


Kate Wallis is a clinical executive leader focused on enabling equitable adoption of innovative healthcare technology solutions ultimately improving on the current standard of care and resulting in optimal health outcomes. As Vice President of Clinical Innovation, she leads a team of seasoned clinicians/professionals who are responsible for actively seeking partnerships within the entire health care ecosystem to explore emerging solutions that challenge current thinking and may revolutionize the standard of care. Her team’s goal is to make these technologies (like digital therapeutics and precision medicine) available to members in a way that minimizes any cost increases and produces real world data that can inform the health care ecosystem.

## IMPACT Cycle 6 Judge Panel:


## Meet the Startups:


Cosmos Pharmaceuticals LLC: FortisKap, a smart adherence device, secures medication with a biometric lock and tracks real-time adherence data between doctor visits.
Detact Diagnostics: RenoTact® is an in vitro diagnostic tool to monitor the status of peritoneal dialysis fluid. RenoTact® is powered by Detact’s VIPER® technology.
Embrace Prevention Care: Helping older adults change behaviors and reduce hospital visits with preventive care provided in partnership with primary care physicians.
JOGO Health: JOGO provides clinically superior virtual rehab using wearables and an app to prevent a second stroke and reduce hospital readmission.
myBiometry: Novel at-home diagnostic technology that combines digital health, machine learning, and clinical services to create a comprehensive solution for asthma (early detection, symptom reduction, attach prevention)
Rubitection: Early skin health monitoring and care management with an easy-to-use measurement probe and care management software.
MiiCare: MiiCare's platform insights help providers maximize health span while Monica the AI health coach empowers older adults to self-care at home.
NucleusRx: NucleusRx empowers healthcare providers to remotely adjust medication doses to optimize Heart Failure patient’s therapy and save cost.
VenoVision: Transform cardiac care for millions of heart failure & at-risk patients with our non-invasive hemodynamic monitoring device & platform.
WatchRX, Inc.: Smartwatch and care coordination solution helps seniors take medications, streamlines care among stakeholders to decrease hospitalizations.

## IMPACT Cycle 6 Prize Sponsors: